Arkolith/Insider Trading/OACC/Form 4

Oaktree Acquisition Holdings III LS, LLC

10% OwnerOaktree Acquisition Corp. III Life Sciences (OACC) · full profile →Form 4 · filed Oct 31, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 30, 2024Conversion(C)34K$10.00$340K584K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 30, 2024Other(J)231K—$04.8M
Oct 30, 2024Conversion(C)7K——117K
Oct 30, 2024Conversion(C)34K——0

Transaction Codes

C
Conversion of a derivative
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-119552) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Oaktree Acquisition Corp. III Life Sciences

Build

Ask your agent about OACC insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950170-24-119552"
Ask your agent
Use Arkolith to summarize insider buying and selling at Oaktree Acquisition Corp. III Life Sciences
over the last 90 days and cite the filings.